Breakthrough Integrin-regulating Therapy for Ocular Health

Risuteganib regulates mitochondrial dysfunction and downregulates oxidative stress response to restore retinal homeostasis

Research suggests that risuteganib interferes with mitochondrial dysfunction that have been implicated in retinal diseases, giving it the potential for a broad-spectrum effect on different pathways of oxidative stress.

Risuteganib reduces mitochondrial dysfunction involved in intermediate dry AMD. By targeting multiple pathways, risuteganib helps reduce the cellular burden of oxidative stress and restores retinal homeostasis.¹